Cosmo Pharmaceuticals N.V. (LON:0RGI)

London flag London · Delayed Price · Currency is GBP · Price in CHF
68.20
+1.80 (2.71%)
At close: Feb 21, 2025
4.06%
Market Cap 962.51M
Revenue (ttm) 157.15M
Net Income (ttm) 58.99M
Shares Out n/a
EPS (ttm) 3.66
PE Ratio 16.32
Forward PE n/a
Dividend 1.68 (2.53%)
Ex-Dividend Date n/a
Volume 915
Average Volume 856
Open 67.60
Previous Close 66.40
Day's Range 67.40 - 68.20
52-Week Range 33.75 - 68.60
Beta 1.30
RSI 67.75
Earnings Date Mar 6, 2025

About Cosmo Pharmaceuticals

Cosmo Pharmaceuticals N.V. focuses on the development and commercialization products for gastroenterology, dermatology, and healthtech worldwide. The company offers GI Genius, a computer-assisted system that uses artificial intelligence in real time to detect colorectal lesions; Winlevi, a prescription medicine used on the skin to treat acne vulgaris; Lialda/Mezavant/Mesavancol, a once-daily mesalamine tablet approved to help get active, mild to moderate ulcerative colitis into remission; Uceris/Cortiment, an oral tablet formulation that delive... [Read more]

Industry Medical - Pharmaceuticals
Sector Healthcare
Founded 1997
Employees 325
Stock Exchange London Stock Exchange
Ticker Symbol 0RGI
Full Company Profile

Financial Performance

Financial numbers in EUR Financial Statements